Align Technology (ALGN)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Align Technology | ALGN | Healthcare | Medical Devices | 95 | 14.7% |
| Current Price (11/15) | $218.47 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 3,864.2 | |||
| Sales Growth Forecast | 15.4% | |||
| Net Profit Margin | 18.2% | |||
| Projected Shares Outstanding | 79.63 | |||
| EPS - Five year Forecast | $18.05 | |||
| Average P/E Ratio | 24.0 | |||
| Projected Average Price | $433.19 | |||
| Price Appreciation (Annualized) | 14.7% | |||
| Annual Dividend Yield | 0.0% | |||
| Projected Annual Return | 14.7% | |||
| Quality | ||||
| Financial Strength | 69 | 17.3 | ||
| EPS Stability | 96 | 24.0 | ||
| Industry Sales Growth Rate | 11.5% | 16.7 | ||
| Industry Net Profit Margin | 15.5% | 14.7 | ||
| Calculated Quality Rating | 76.6 | |||
| Fool CAPS | ||||
Total Players
501
Outperforms
51
Underperforms
All-Stars (133)
121
Outperforms (91%)
12
Underperforms
|
||||
| Fundamental Data Updated: 11/11/2022 | ||||